{"id":"W2159831861","doi":"10.1016/s0140-6736(07)60946-5","title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","year":2007,"lang":"en","type":"article","venue":"The Lancet","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1315,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Vaccine trial; Cervical intraepithelial neoplasia; Cervical cancer; Vaccine efficacy; Vaccination; Interim analysis; Cohort; Clinical endpoint; Internal medicine; Cytology; Clinical trial; Gynecology; Oncology; Virology; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06427941154357125,"score_gpt":0.3983157518856838,"score_spread":0.3340363403421125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}